PEGylation
- FDA Approves Palopegteriparatide for Hypoparathyroidism
- FDA Approved PEGylated Drugs By 2024
- Alleviating PEG Allergic Reactions: Free PEG Intervention Insights
- Anti-PEG Antibody Response to PEGylated Liposomes
- PEG‐rhG‐CSF for Neutropenia
- PEGylated Liposomes in the Clinic and Clinical Trials
- PEG-Interleukin-2 (PEG-IL-2) Therapeutics in Cancer
- Long Acting PEGylated Interferon: Application of PEG
- PEG G-CSF With Prolonged Biological Activity
- Potential Limitations of PEGylated Therapeutic Proteins